Table 1.
Baseline characteristics of participants
| Variable | Arylia (N = 95) | Prolia® (N = 95) |
|---|---|---|
| Age, year | 61.59 (5.94) | 60.60 (6.62) |
| Height, cm | 153.14 (5.88) | 154.59 (5.74) |
| Weight, kg | 66.44 (11.28) | 64.72 (9.88) |
| Body-mass index, kg/m2 | 28.35 (4.69) | 27.10 (4.09) |
| T score, SD | ||
| Spine (L1–L4) | − 3.09 (0.54) | − 3.10 (0.54) |
| Total hip | − 1.27 (0.83) | − 1.29 (0.87) |
| Femoral neck | − 1.84 (0.83) | − 1.88 (0.68) |
| 25 (OH) vitamin D3, ng/mL | 41.80 (19.48) | 46.53 (22.15) |
| Albumin-adjusted serum calcium, mg/dL | 9.15 (0.55) | 9.10 (0.53) |
| Previous bisphosphonate use | 6 | 2 |
Data are mean (SD)